1. ホーム
  2. 一覧
論文 特許

論文 - 一覧

  • 26 Hits
  • 検索条件 : 絞込み (MeSH = Cholangiocarcinoma / drug therapy*)
生物種 リソース名 タイトル
ヒト・動物細胞 RGM1(RCB0876) Porphylipoprotein Accumulation and Porphylipoprotein Photodynamic Therapy Effects Involving Cancer Cell-Specific Cytotoxicity.
ヒト・動物細胞 HuCCT1(RCB1960) Histone deacetylase inhibitor enhances the anti-tumor effect of gemcitabine: a special reference to gene-expression microarray analysis.
ヒト・動物細胞 SSP-25(RCB1293) , TFK-1(RCB2537) Anti-Glypican-1 Antibody-drug Conjugate as Potential Therapy Against Tumor Cells and Tumor Vasculature for Glypican-1-Positive Cholangiocarcinoma.
ヒト・動物細胞 HuCCT1(RCB1960) , SSP-25(RCB1293) , RBE(RCB1292) , YSCCC(RCB1549) , TGBC24TKB(RCB1196) , TFK-1(RCB2537) Synergistic antiproliferative effects of an mTOR inhibitor (rad001) plus gemcitabine on cholangiocarcinoma by decreasing choline kinase activity.
ヒト・動物細胞 HuCCT1(RCB1960) Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.
ヒト・動物細胞 HuCCT1(RCB1960) , HuH-28(RCB1943) Quinoline-based clioquinol and nitroxoline exhibit anticancer activity inducing FoxM1 inhibition in cholangiocarcinoma cells.
ヒト・動物細胞 HuCCT1(RCB1960) , YSCCC(RCB1549) Statins induce apoptosis and inhibit proliferation in cholangiocarcinoma cells.
ヒト・動物細胞 SSP-25(RCB1293) , HuH-28(RCB1943) Lovastatin overcomes gefitinib resistance through TNF-α signaling in human cholangiocarcinomas with different LKB1 statuses in vitro and in vivo.
ヒト・動物細胞 RBE(RCB1292) Nintedanib inhibits intrahepatic cholangiocarcinoma aggressiveness via suppression of cytokines extracted from activated cancer-associated fibroblasts.
ヒト・動物細胞 SSP-25(RCB1293) , HuCCT1(RCB1960) Heteronemin Induces Anti-Proliferation in Cholangiocarcinoma Cells via Inhibiting TGF-β Pathway.
ヒト・動物細胞 HuCCT1(RCB1960) , TFK-1(RCB2537) Targeting c-MET by Tivantinib through synergistic activation of JNK/c-jun pathway in cholangiocarcinoma.
ヒト・動物細胞 HuCCT1(RCB1960) , RBE(RCB1292) GNS561, a new lysosomotropic small molecule, for the treatment of intrahepatic cholangiocarcinoma.
ヒト・動物細胞 Hep G2(RCB1886) Angiotensin receptor blockade attenuates cholangiocarcinoma cell growth by inhibiting the oncogenic activity of Yes-associated protein.
ヒト・動物細胞 TFK-1(RCB2537) Combined Gemcitabine and Metronidazole Is a Promising Therapeutic Strategy for Cancer Stem-like Cholangiocarcinoma.
ヒト・動物細胞 TFK-1(RCB2537) A novel photodynamic therapy-based drug delivery system layered on a stent for treating cholangiocarcinoma.
ヒト・動物細胞 HuCCT1(RCB1960) , TFK-1(RCB2537) Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti-apoptotic proteins.
ヒト・動物細胞 TKKK(RCB1907) Axitinib (AG-013736), an oral specific VEGFR TKI, shows potential therapeutic utility against cholangiocarcinoma.
ヒト・動物細胞 HuCCT1(RCB1960) Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma.
ヒト・動物細胞 RBE(RCB1292) , TFK-1(RCB2537) Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cells.
ヒト・動物細胞 Growth inhibition and mechanism of action of p-dodecylaminophenol against refractory human pancreatic cancer and cholangiocarcinoma.